Portside Wealth Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $694K | Buy |
1,322
+208
| +19% | +$109K | 0.1% | 202 |
|
|
2025
Q1 | $707K | Buy |
1,114
+338
| +44% | +$214K | 0.12% | 189 |
|
|
2024
Q4 | $553K | Buy |
776
+52
| +7% | +$37K | 0.09% | 213 |
|
|
2024
Q3 | $761K | Buy |
724
+93
| +15% | +$97.8K | 0.13% | 170 |
|
|
2024
Q2 | $663K | Buy |
631
+32
| +5% | +$33.6K | 0.13% | 171 |
|
|
2024
Q1 | $577K | Buy |
599
+53
| +10% | +$51K | 0.11% | 196 |
|
|
2023
Q4 | $480K | Buy |
546
+58
| +12% | +$50.9K | 0.09% | 216 |
|
|
2023
Q3 | $401K | Buy |
488
+90
| +23% | +$74K | 0.08% | 219 |
|
|
2023
Q2 | $286K | Buy |
+398
| New | +$286K | 0.05% | 264 |
|